FDA Adverse Event Injury Summary report: N

BE-PLS 2050#PERMANENT LIFE SUPPORT SET

MDR report key: 4332318 · Received December 3, 2014

Report

Report Number
8010762-2014-01325
Event Type
Injury
Date Received
December 3, 2014
Date of Event
November 6, 2014
Report Date
November 6, 2014
Manufacturer
MAQUET CARDIOPULMONARY AG
Product Code
DTZ
PMA / PMN Number
K101153
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

MAQUET CARDIOPULMONARY IS AWARE OF SIMILAR COMPLAINTS. ADDITIONAL INFO: THE PRODUCT MENTIONED IS NOT DISTRIBUTED TO THE US, BUT THE PRODUCT WITH CONTRIBUTING DESIGN FUNCTION TO THE AFFECTED COMPONENT (QUADROX-ID) IS REGISTERED UNDER 510(K): K101153. MAQUET CARDIOPULMONARY IS AWARE OF SIMILAR COMPLAINTS. THE DEVICES DISPLAYED A SIMILAR MALFUNCTION WHICH WERE TESTED AND EVALUATED UNDER AN OPTICAL MICROSCOPE. DELAMINATION OF SOME GAS FIBERS WAS OBSERVED WHICH ALLOWED FOR THE PRIMING SOLUTION OR BLOOD TO FLOW INSIDE THE GAP BETWEEN THE GAS FIBERS AND POLYURETHANE. GRAVITY THEN ALLOWED FOR PASSAGE TO THE GAS EXITING PATH ALONG THE HOUSING. THE MOST PROBABLE ROOT-CAUSE IS THE DELAMINATION OF THE HOLLOW GAS FIBERS FROM THE POLYURETHANE POTTING AREA. A REVIEW OF THE QUAL CONTROL PROCESS CONFIRMS THAT 100% FUNCTIONAL INSPECTION FOR LEAKAGE IS PERFORMED DURING PRODUCTION. MAQUET CARDIOPULMONARY AG HAS INITIATED AN INTERNAL PROCESS (B)(6) TO ADDRESS THE APPROPRIATE CORRECTIVE AND PREVENTIVE ACTION. A SUPPLEMENTAL MEDWATCH WILL BE SUBMITTED WHEN NEW INFO BECOMES AVAILABLE.

Description of Event or Problem · 1

IT WAS REPORTED THAT AFTER INITIATION OF ECMO (EXTRA CORPOREAL MEMBRANE OXYGENATION). 20-40 ML OF BLOOD DRIPPED OUT OF THE GAS OUTLET. THE DEVICE WAS CHANGED OUT. (B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
779815 BE-PLS 2050#PERMANENT LIFE SUPPORT SET TUBING SET DTZ MAQUET CARDIOPULMONARY AG 70099745

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention